Roche's Actemra falls short in Italian study in early-stage COVID-19 pneumonia

Roche’s Actemra, one of several anti-inflammatory drugs in testing against coronavirus, didn’t help patients with early-stage COVID-19 pneumonia, an Italian study found, though it might still prove useful for more advanced cases.